Net Zero power and hydrogen: capacity requirements for flexibility

Complete

Value

£70,000

Classifications

  • Research and development services and related consultancy services

Tags

  • tender

Submission Deadline

2 years ago

Published

2 years ago

Description

The Climate Change Act sets legally-binding targets for the UK's greenhouse gas emissions. It includes a 2050 target for Net Zero emissions by 2050 compared to 1990 levels, and a series of five-yearly carbon budgets towards that 2050 target. 

In 2020 the CCC advised the Government that the Sixth Carbon Budget, covering the period 2033-37, should be set at 78% below 1990 levels.  And  that the UK's Nationally Determined Contribution (NDC) to the UN global process should be a 68% reduction in greenhouse aas emissions below 1990 levels by 2030. 

The Government have accepted both these recommendations, and legislated the Sixth Carbon Budget in June 2021.

Underpinning the CCC's advice on the Sixth Budget and the NDC was a set of scenarios for emissions from electricity generation to 2050.  These informed a recommendation to Government, as part of the advice, that use of unabated gas for electricity generation should be phased out by 2035 - meaning all electricity generation would be low-carbon from that date. In its Net Zero Strategy the Government have now adopted that target. 

A core duty of the CCC under the Climate Change Act is to publish an annual report for Parliament monitoring progress towards meeting carbon budgets. 

The CCC has previously developed a set of tracking indicators to monitor progress on an annual basis. For the 2022 Progress Report the CCC will be refreshing these indicators, in light of the new Net Zero and Sixth Carbon Budget targets.

As part of this process the CCC would like to produce new indicators focusing on the capacity deployment pathway for schedulable low-carbon generation and for other sources of flexibility, including interactions with the production of hydrogen.


**** See Specification for more detail ****

Documents

Premium

Bypass the hassle of outdated portals. Get all the information you need right here, right now.

  • Contract Agreement

    The official contract terms, conditions, and scopes of work.

    Download
  • Award Notice

    Details on the tender award and selected suppliers.

    Download

Similar Contracts

Open

NICE External Assessment Groups Framework

NICE is seeking to commission external assessment groups (EAGs) which will provide a range of services to support its programmes and related activities. Suppliers can bid for one or more Lots. NICE will consider bids from multidisciplinary EAGs with knowledge and expertise in health technology assessment. NICE will consider proposals from consortia or networks of organisations meeting the selection criteria and encourages potential suppliers to explore collaborations that will result in the offer of a comprehensive range of services. Main activities of the EAGs in each framework NICE commissions EAGs to support its guidance development programmes in the following key areas and tasks: Lot 1 - Clinical and Economic Evidence Assessment Including: critical appraisal of clinical and economic evidence to support the development of NICE outputs; evidence synthesis; de novo economic modelling and critiquing and revising existing models; systematic review and meta-analysis; supporting scoping of evaluation topics; user preference assessment or structured elicitation, confirmation and review of regulatory status to the evaluation programmes. Lot 2 - Technical and Decision Support Including: providing advanced methodological and analytical advice and support to NICE's technical teams and committees on all guideline and technology types that are in remit for NICE, including Health Technology Evaluation (HTE) outputs (pharmaceuticals, diagnostics, medical device and digital technologies, combination products etc.) and Guidelines topics covering public health, social and clinical areas. This includes providing evidence synthesis, data analytics, complex decision analytical modelling and health economic support; providing a technical rapid response service and quality assurance input for guidance products; development and provision of guidance methods training, covering evidence synthesis, data analytics, decision analytical modelling and health economics. Lot 3 - Evidence Generation to support Access Including: Evidence generation using existing registers or databases, feasibility studies, data protocol development, pilot studies; data collection and active surveillance; data linkage and complex modelling and/or analyses; register set up and close. Lot 4 Research governance & ethics support Including: advice on research governance and ethics support including access to a research ethics committee.

Open

NICE External Assessment Groups Framework

NICE is seeking to commission external assessment groups (EAGs) which will provide a range of services to support its programmes and related activities. Suppliers can bid for one or more Lots. NICE will consider bids from multidisciplinary EAGs with knowledge and expertise in health technology assessment. NICE will consider proposals from consortia or networks of organisations meeting the selection criteria and encourages potential suppliers to explore collaborations that will result in the offer of a comprehensive range of services. Main activities of the EAGs in each framework NICE commissions EAGs to support its guidance development programmes in the following key areas and tasks: Lot 1 - Clinical and Economic Evidence Assessment Including: critical appraisal of clinical and economic evidence to support the development of NICE outputs; evidence synthesis; de novo economic modelling and critiquing and revising existing models; systematic review and meta-analysis; supporting scoping of evaluation topics; user preference assessment or structured elicitation, confirmation and review of regulatory status to the evaluation programmes. Lot 2 - Technical and Decision Support Including: providing advanced methodological and analytical advice and support to NICE's technical teams and committees on all guideline and technology types that are in remit for NICE, including Health Technology Evaluation (HTE) outputs (pharmaceuticals, diagnostics, medical device and digital technologies, combination products etc.) and Guidelines topics covering public health, social and clinical areas. This includes providing evidence synthesis, data analytics, complex decision analytical modelling and health economic support; providing a technical rapid response service and quality assurance input for guidance products; development and provision of guidance methods training, covering evidence synthesis, data analytics, decision analytical modelling and health economics. Lot 3 - Evidence Generation to support Access Including: Evidence generation using existing registers or databases, feasibility studies, data protocol development, pilot studies; data collection and active surveillance; data linkage and complex modelling and/or analyses; register set up and close. Lot 4 Research governance & ethics support Including: advice on research governance and ethics support including access to a research ethics committee.

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Timeline complete